Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neurotechnology In Brief

This article was originally published in The Gray Sheet

Executive Summary

Neurodevices show growth: Neurodevices generated $7.1 billion in global revenue in 2009, a 15% jump over the previous year, according to neurotech consulting firm NeuroInsights. Neurodiagnostics revenue, on the other hand, dropped 11% year-over-year, to $15 billion. But the neurotechnology field as a whole remained an attractive investment, with the broader sector garnering $1.58 billion in venture capital investment during the year, up 9.5%. The investment activity comes as brain-related illness remains the largest unmet medical need, with 2 billion people affected worldwide, according to NeuroInsights. The findings were included in NeuroInsights' Neurotechnology Industry 2010 Report, highlights of which were presented May 19 at the Neurotech Investing and Partnering Conference in Boston
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT028945

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel